MIRO logo

Miromatrix Medical Inc. Stock Price

NasdaqCM:MIRO Community·US$93.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

MIRO Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

MIRO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with limited growth.

6 Risks
1 Reward

Miromatrix Medical Inc. Key Details

US$958.0k

Revenue

US$500.0k

Cost of Revenue

US$458.0k

Gross Profit

US$27.9m

Other Expenses

-US$27.4m

Earnings

Last Reported Earnings
Sep 30, 2023
Next Reporting Earnings
n/a
-1.00
47.81%
-2,861.11%
2.5%
View Full Analysis

About MIRO

Founded
2009
Employees
76
CEO
Jeffrey Ross
WebsiteView website
www.miromatrix.com

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. The company’s proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. It has collaborations with Baxter, CareDx, The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

Recent MIRO News & Updates

Recent updates

No updates